Price
Target price
?
?
-3.450%
-0.001
-3.450%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Investigator Resources Ltd Stock
Investigator Resources Ltd took a tumble today and lost -€0.001 (-3.450%).
Pros and Cons of Investigator Resources Ltd in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Investigator Resources Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Investigator Resources Ltd | -3.450% | 14.286% | 9.804% | 55.556% | -67.816% | 33.333% | -21.127% |
| Strategic Energy Resources | -7.230% | 9.220% | -15.847% | 15300.000% | 15300.000% | 1611.111% | 227.660% |
| Black Ridge Mining Ltd | -3.850% | -7.407% | -7.407% | 2400.000% | 1150.000% | 108.333% | 92.308% |
| Elementos Ltd | -7.080% | -4.369% | 10.674% | 155.844% | 17.964% | 194.030% | -7.294% |
News
Palvella Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Palvella Therapeutics, Inc.? Here are five stocks we like better.
- Palvella remains on track to submit its NDA for QTORIN rapamycin in microcystic lymphatic
Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout
Key Points
- Interested in Turn Therapeutics Inc.? Here are five stocks we like better.
- Turn Therapeutics refined the stage two design of its GX-03 phase II eczema trial after an interim